These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 17078922)
21. Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120. Balzarini J Curr Opin HIV AIDS; 2006 Sep; 1(5):355-60. PubMed ID: 19372833 [TBL] [Abstract][Full Text] [Related]
22. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282 [TBL] [Abstract][Full Text] [Related]
23. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex. Welman M; Lemay G; Cohen EA Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629 [TBL] [Abstract][Full Text] [Related]
25. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity. Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730 [TBL] [Abstract][Full Text] [Related]
26. A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity. Manetti F; Tintori C; Armand-Ugón M; Clotet-Codina I; Massa S; Ragno R; Esté JA; Botta M J Chem Inf Model; 2006; 46(3):1344-51. PubMed ID: 16711753 [TBL] [Abstract][Full Text] [Related]
27. Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26. Wang YH; Davies AH; Jones IM Virology; 1995 Apr; 208(1):142-6. PubMed ID: 11831694 [TBL] [Abstract][Full Text] [Related]
28. HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. Ronaldson PT; Bendayan R J Neurochem; 2008 Aug; 106(3):1298-313. PubMed ID: 18485102 [TBL] [Abstract][Full Text] [Related]
29. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor. Deng Y; Zheng Q; Ketas TJ; Moore JP; Lu M Biochemistry; 2007 Apr; 46(14):4360-9. PubMed ID: 17371053 [TBL] [Abstract][Full Text] [Related]
30. Affinity hemodialysis for antiviral therapy. II. Removal of HIV-1 viral proteins from cell culture supernatants and whole blood. Tullis RH; Duffin RP; Zech M; Ambrus JL Blood Purif; 2003; 21(1):58-63. PubMed ID: 12566663 [TBL] [Abstract][Full Text] [Related]
31. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120. Wu Z; Van Ryk D; Davis C; Abrams WR; Chaiken I; Magnani J; Malamud D AIDS Res Hum Retroviruses; 2003 Mar; 19(3):201-9. PubMed ID: 12689412 [TBL] [Abstract][Full Text] [Related]
32. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities. Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125 [TBL] [Abstract][Full Text] [Related]
33. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells. Clayton R; Ohagen A; Goethals O; Smets A; Van Loock M; Michiels L; Kennedy-Johnston E; Cunningham M; Jiang H; Bola S; Gutshall L; Gunn G; Del Vecchio A; Sarisky R; Hallenberger S; Hertogs K J Virol Methods; 2007 Jan; 139(1):17-23. PubMed ID: 17034868 [TBL] [Abstract][Full Text] [Related]
34. Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors. Mann A; Friedrich N; Krarup A; Weber J; Stiegeler E; Dreier B; Pugach P; Robbiani M; Riedel T; Moehle K; Robinson JA; Rusert P; Plückthun A; Trkola A J Virol; 2013 May; 87(10):5868-81. PubMed ID: 23487463 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of certain strains of HIV-1 by cell surface polyanions in the form of cholesterol-labeled oligonucleotides. Ahn KS; Ou W; Silver J Virology; 2004 Dec; 330(1):50-61. PubMed ID: 15527833 [TBL] [Abstract][Full Text] [Related]
36. A novel cell-free translation/glycosylation system prepared from insect cells. Tarui H; Imanishi S; Hara T J Biosci Bioeng; 2000; 90(5):508-14. PubMed ID: 16232900 [TBL] [Abstract][Full Text] [Related]
37. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120. Augustin LA; Fantini J; Mootoo DR Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516 [TBL] [Abstract][Full Text] [Related]
38. [Pregnancy determination by the detection of early pregnancy associated protein]. Leipe S; Straube W; Loh M; Droese B Zentralbl Gynakol; 1988; 110(17):1059-64. PubMed ID: 3176745 [TBL] [Abstract][Full Text] [Related]
39. High level stable expression of recombinant HIV gp120 in glutamine synthetase gene deficient HEK293T cells. Zou Z; Wang R; Go EP; Desaire H; Sun PD Protein Expr Purif; 2021 May; 181():105837. PubMed ID: 33529763 [TBL] [Abstract][Full Text] [Related]